Cresco Labs Expands Brand Portfolio to Florida, Launching Expansive Product Lineup in March
Cresco Labs (CSE:CL, OTCQX:CRLBF) has launched multiple proprietary cannabis brands in Florida, catering to the diverse needs of medical patients. This includes popular brands like High Supply, Good News, and the new Sunnyside Chews. These products are tailored for quality and consistency, with options such as 500mg Carts, disposable vape pens, and effect-driven gummies. The expansion emphasizes Cresco’s commitment to quality and availability, enhancing its market position in the growing Florida cannabis market.
- Launch of multiple proprietary brands in Florida enhances product diversity.
- Introduction of Sunnyside Chews offers effect-driven gummies to meet market needs.
- Expansion to Florida strengthens Cresco's market presence as a leading cannabis operator.
- None.
Expansion of proprietary brands demonstrates Cresco Labs’ continued focus on offering quality cannabis products at different price points to meet the diverse needs of Florida’s patient community
“We’ve demonstrated our ability to reach leading market share positions in large medical markets based on the strength of our products and the value we provide patients. We’re proud to offer those popular brands to
Throughout March,
-
Supply – Cresco’s approachably priced, quality cannabis brand offering bulk options enters
Florida under the name, Supply. Available 500mg Carts offer unique strain blends made with100% high THC oil, no additives or fillers, and live terpenes delivering natural aromas and flavors extracted from fresh frozen flower. A 1g offering is launching soon.
- Good News – Good News offers 300mg disposable, ready to use vape pens in four occasion-based flavors—Berry (Me Time), Orange (Brunch), Melon (Friyay), and Mint Chocolate (Vegas). Good News products are developed to deliver quality, safe, and consistent cannabis experiences through easy to use and benefit-forward forms formulated to elevate life’s best moments.
-
Sunnyside Chews – Nuances of OMMU regulations created an opportunity for Cresco to develop the
Florida market’s first effect-driven gummy under a new brand, Sunnyside Chews. Using a proprietary blend of distillate oil and Live Rosin terpenes with no additives or fillers, Sunnyside Chews are precisely dosed for consistent cannabis experiences and deliver 10mg of THC per Chew. The product lineup is gluten free and features four flavors and effects—Watermelon (Sativa ), Sour Pineapple (Sativa ), Orange (Hybrid), and Blue Raspberry (Indica). 10 Chews and 100mg of THC per pouch.
- Remedi – Tailored to meet the needs of patients, Remedi products come in precise doses and forms similar to other health and wellness products. Remedi offers a Tincture, Balm, and RSO Syringe. Remedi Tinctures are infused with 500mg of THC to help patients looking for quick relief with just a few drops under the tongue. Remedi Balm contains 500mg of THC in a 2oz jar. It’s also paraben free, contains soothing ingredients like mango butter, almond oil, and coconut oil, and is recommended for localized, non-intoxicating relief from bodily discomfort. Finally, Remedi RSO Syringes have 1000mg, strain specific offerings for patients seeking potent dose of relief.
For more information about Sunnyside or to place online orders, visit www.Sunnyside.shop. To learn more about Cresco, visit www.crescolabs.com.
About
Facebook:
Instagram:
Twitter:
Forward-Looking Statements
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under “Risk Factors” in the Company’s Annual Information Form for the year ended
View source version on businesswire.com: https://www.businesswire.com/news/home/20220317005317/en/
Media:
Chief Communications Officer
press@crescolabs.com
Investors:
Senior Vice President, Investor Relations
investors@crescolabs.com
For general
312-929-0993
info@crescolabs.com
Source:
FAQ
What new products did Cresco Labs launch in Florida?
What is the significance of Cresco Labs' expansion in Florida?